140 related articles for article (PubMed ID: 6090968)
1. Inhibition of seizures induced by picrotoxin and electroshock by cholecystokinin octapeptides and their fragments in rats after intracerebroventricular administration.
Kádár T; Pesti A; Penke B; Telegdy G
Neuropharmacology; 1984 Aug; 23(8):955-61. PubMed ID: 6090968
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity and dose-effect relationships of the antagonism of picrotoxin-induced seizures by cholecystokinin, fragments and analogues of cholecystokinin in mice.
Kádár T; Pesti A; Penke B; Tóth G; Zarándi M; Telegdy G
Neuropharmacology; 1983 Oct; 22(10):1223-9. PubMed ID: 6316193
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of electroshock-induced seizures by cholecystokinin-related peptides in mice.
Kádár T; Borda L; Zarándi M; Penke B; Kovács K; Telegdy G
Acta Physiol Hung; 1987; 69(1):43-50. PubMed ID: 3591354
[TBL] [Abstract][Full Text] [Related]
4. Multiple treatment potentiates the anticonvulsive activity of cholecystokinin octapeptides.
Kádár T; Penke B; Pesti A; Telegdy G
Peptides; 1985; 6(6):1009-14. PubMed ID: 3834411
[TBL] [Abstract][Full Text] [Related]
5. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide.
Kádár T; Fekete M; Telegdy G
Acta Physiol Acad Sci Hung; 1981; 58(4):269-74. PubMed ID: 6291322
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of haloperidol-induced catalepsy by cholecystokinin octapeptides after central administration to rats.
Kádár T; Penke B; Kovács K; Telegdy G
Neuropharmacology; 1985 Jun; 24(6):577-80. PubMed ID: 2862602
[TBL] [Abstract][Full Text] [Related]
7. The effects of sulfated and nonsulfated cholecystokinin octapeptides on electroconvulsive shock-induced retrograde amnesia after intracerebroventricular administration in rats.
Kádár T; Penke B; Kovács K; Telegdy G
Neuropeptides; 1984 Mar; 4(2):127-35. PubMed ID: 6325992
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of tail-pinch-induced food intake by cholecystokinin octapeptides and their fragments.
Telegdy G; Kádár T; Kovács K; Penke B
Life Sci; 1984 Jul; 35(2):163-70. PubMed ID: 6330485
[TBL] [Abstract][Full Text] [Related]
9. Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats.
Fekete M; Lengyel A; Hegedüs B; Penke B; Zarándy M; Tóth G; Telegdy G
Eur J Pharmacol; 1984 Feb; 98(1):79-91. PubMed ID: 6325212
[TBL] [Abstract][Full Text] [Related]
10. Cataleptogenic and anticataleptic activity produced by cholecystokinin octapeptides in mice.
Kádár T; Borda L; Penke B; Kovács K; Telegdy G
Neuropeptides; 1985 Jun; 6(3):259-68. PubMed ID: 4040614
[TBL] [Abstract][Full Text] [Related]
11. Depression of rat feeding in familiar and novel environment by sulfated and nonsulfated cholecystokinin octapeptide.
Kádár T; Penke B; Kovács K; Telegdy G
Physiol Behav; 1985 Mar; 34(3):395-400. PubMed ID: 4011720
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant effects of careulein and cholecystokinin octapeptide, compared with those of diazepam.
Zetler G
Eur J Pharmacol; 1980 Jul; 65(2-3):297-300. PubMed ID: 6249626
[TBL] [Abstract][Full Text] [Related]
13. Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid.
Zetler G
Neurosci Lett; 1981 Jul; 24(2):175-80. PubMed ID: 6265841
[TBL] [Abstract][Full Text] [Related]
14. Passive avoidance deficit following intracerebroventricular administration of cholecystokinin tetrapeptide amide in rats.
Katsuura G; Itoh S
Peptides; 1986; 7(5):809-14. PubMed ID: 3797342
[TBL] [Abstract][Full Text] [Related]
15. Ethosuximide suppresses seizures and lethality induced by picrotoxin in developing rats.
Velísková J; Velísek L; Mares P; Rokyta R; Micianiková D
Pharmacol Biochem Behav; 1993 Apr; 44(4):975-9. PubMed ID: 8469708
[TBL] [Abstract][Full Text] [Related]
16. Interaction between GABAergic anticonvulsants and the NMDA receptor antagonist MK 801 against MES- and picrotoxin-induced convulsions in rats.
Kulkarni SK; Ticku MK
Life Sci; 1989; 44(18):1317-23. PubMed ID: 2541293
[TBL] [Abstract][Full Text] [Related]
17. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
[TBL] [Abstract][Full Text] [Related]
18. Caerulein and cholecystokinin octapeptide (CCK-8): sedative and anticonvulsive effects in mice unaffected by the benzodiazepine antagonist Ro 15-1788.
Zetler G
Neurosci Lett; 1982 Mar; 28(3):287-90. PubMed ID: 6281694
[TBL] [Abstract][Full Text] [Related]
19. Effects of cholecystokinin on apomorphine-induced changes of motility in rats.
Katsuura G; Itoh S; Rehfeld JF
Neuropharmacology; 1984 Jul; 23(7A):731-4. PubMed ID: 6089021
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methylphenidate and picrotoxin.
Zetler G
Eur J Pharmacol; 1983 Oct; 94(3-4):261-70. PubMed ID: 6140174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
